Cytokine profile depending on titers of anti-SARS-CoV-2 IgG in the blood plasma of healthy volunteers

被引:0
|
作者
Krenytska, Daryna [1 ]
Rachkovska, Antonina [1 ]
Karbovskyy, Vitalii [2 ]
Raksha, Nataliia [1 ]
Vovk, Tetiana [1 ]
Savchuk, Olexii [1 ]
Ostapchenko, Liudmyla [1 ]
Halenova, Tetiana [1 ]
机构
[1] Taras Shevchenko Natl Univ Kyiv, Educ & Sci Ctr, Inst Biol & Med, 64-13 Volodymyrska Str, UA-01601 Kiev, Ukraine
[2] LLC BIOPHARMA PLASMA, Kiev, Ukraine
关键词
IgG; cytokine profile; donors;
D O I
10.4081/jbr.2023.11256
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Post-COVID-19 conditions are the subject of extensive scientific study. It is known that system disorders may persist in people who recover from COVID-19 for 3 to 12 months (in most cases). The first line of systemic disorders is dysfunction of the immune system, especially the cytokine profile. The mechanism of the launch of immune complications is currently unknown. We hypothesized that anti-SARS-CoV-2 IgG might trigger the development of post-COVID-19 complications. Our research aimed to study the cytokine profile (including IL-1 beta, IL-4, IL-6, IL-8, IL-10, IL-12 beta, TNF-alpha, IFN-gamma) and the transcription factor NF-kB in the blood plasma of donor groups depending on various titers of anti-SARS-CoV-2 IgG. We determined the qualitative values of the cytokine parameters using ELISA (Enzyme Linked Immunosorbent Assay). We estimated the changes in the cytokine profiles in all donor groups. Differences between donor groups were established for each research parameter. We detected changes in NF-kappa B levels as a key transcription factor for the expression of inflammatory cytokines. The highest level was found in the donor group with a titer of anti-SARS-CoV-2 IgG 75 +/- 5 Index (S/C). We detected some differences between donor groups in the levels of pro-inflammatory cytokines compared to a reference point. IL-1 beta, IL-6, IL-8, INF-gamma, and TNF-alpha levels changed in most donor groups with titers of anti-SARS-CoV-2 IgG >= 10 +/- 3 Index (S/C). In addition, we showed that the decrease in anti-inflammatory cytokine IL-4 in donor groups ranged from the titer of anti-SARS-CoV-2 IgG 55 +/- 5 Index (S/C) to 85 +/- 5 Index (S/C), but these changes for the anti-inflammatory cytokine IL-10 were not detected. We found that the cytokine profile may be affected during post-COVID-19 conditions. The cytokine profiles of the donor groups changed depending on the titers of anti-SARS-CoV-2 IgG. The obtained results testify to the fact that the antibody subpopulation may be a key reason for immune dysfunction, influencing the development of other pathological processes.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Qualification of High Titer COVID-19 Convalescent Plasma with an Anti-SARS-CoV-2 IgG Quantitative Test
    Contestable, P.
    Di Germanio, C.
    Grebe, E.
    Stone, M.
    Simmons, G.
    Deng, X.
    Lanteri, M.
    Green, V.
    Busch, M.
    TRANSFUSION, 2023, 63 : 234A - 235A
  • [42] The Influence of COVID-19 Vaccinations and Previous Infection on Donor anti-Sars-Cov-2 Titers
    Gammon, Richard
    Gannett, Michael
    Prichard, Alicia Bellido
    Reik, Rita A.
    TRANSFUSION, 2021, 61 : 76A - 77A
  • [43] Are anti-SARS-CoV-2 S/N IgG/IgM antibodies always predictive of previous SARS-CoV-2 infection?
    Lippi, Giuseppe
    Henry, Brandon M.
    Pighi, Laura
    De Nitto, Simone
    Salvagno, Gian Luca
    ADVANCES IN LABORATORY MEDICINE-AVANCES EN MEDICINA DE LABORATORIO, 2023, 4 (02): : 175 - 179
  • [44] Seroprevalence of anti-SARS-CoV-2 antibodies and risk factors among healthy blood donors in Luanda, Angola
    Sebastiao, Cruz S.
    Galangue, Manuela
    Gaston, Celestina
    Van-Dunen, Rui
    Quivinja, Joltim
    Lunbungululo, Emiliana
    Alfredo, Domingos
    Sozinho, Alberto
    Teixeira, Alice
    Manico, Eunice
    Machado, Deodete
    Mateus, Antonio
    David, Zinga
    Paixao, Joana
    Neto, Zoraima
    de Vasconcelos, Jocelyne Neto
    Morais, Joana
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [45] Using Dried Blood Spots to Quantitatively Detect Anti-SARS-CoV-2 IgG Antibodies by ELISA: A Validation Study
    Ylade, Michelle
    Aziz, Asma Binte
    Daag, Jedas Veronica
    Crisostomo, Maria Vinna
    Agrupis, Kristal-An
    Maronilla, Maria Angela
    Hong, Chloe Sye Lim
    Kim, Hwa Young
    Njau, Irene
    Lopez, March Helena Jane
    Deen, Jacqueline
    Kim, Deok Ryun
    You, Young Ae
    Kang, Sophie S. Y.
    Marks, Florian
    Tadesse, Birkneh Tilahun
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2024, 111 (02): : 391 - 395
  • [46] Anti-SARS-CoV-2 Spike Antibody Titers and Neutralizing Antibodies in Vaccinated Rheumatoid Arthritis Patients
    Furukawa, Hiroshi
    Oka, Shomi
    Higuchi, Takashi
    Nakama, Moriyuki
    Nagai, Nobuhiro
    Tohma, Shigeto
    VACCINES, 2022, 10 (08)
  • [47] Dynamics of anti-SARS-CoV-2 antibodies in repeat convalescent plasma donors
    Franchini, Massimo
    Glingani, Claudia
    Liumbruno, Giancarlo Maria
    Mengoli, Carlo
    TRANSFUSION AND APHERESIS SCIENCE, 2021, 60 (06)
  • [48] Evolution of Anti-SARS-CoV-2 IgG Antibody and IgG Avidity Post Pfizer and Moderna mRNA Vaccinations
    Bliden, Kevin
    Liu, Tiancheng
    Sreedhar, Deepika
    Tantry, Udaya
    Kost, Jessica
    Hsiung, Jessica
    Zhao, Su
    Shan, Dingying
    Usman, Abira
    Walia, Naval
    Cho, Alastair
    Jerijan, Christophe
    Dai, Hongjie
    Tang, Meijie
    Gurbel, Paul A.
    CIRCULATION, 2021, 144
  • [49] Reactivity of anti-SARS-CoV-2 antibodies in Serbian voluntary blood donors
    Bezanovic, Milomir Radoslav
    Obradovic, Zorana Budakov
    Bujandric, Nevenka
    Kocic, Neda
    Milanovic, Mirjana Krga
    Majkic, Milan
    Obrovski, Boris
    Grujic, Jasmina
    TRANSFUSION MEDICINE, 2024, 34 (03) : 200 - 210
  • [50] A trend of dropping anti-SARS-CoV-2 plaque reduction neutralization test titers over time in Canadian convalescent plasma donors
    Drews, Steven J.
    Devine, Dana V.
    McManus, Janet
    Mendoza, Emelissa
    Manguiat, Kathy
    Wood, Heidi
    Girardin, Roxie
    Dupuis, Alan
    McDonough, Kathleen
    Drebot, Michael
    TRANSFUSION, 2021, 61 (05) : 1440 - 1446